임파선내항원특이면역요법Intralymphatic allergen-specific immunotherapy
- Other Titles
- Intralymphatic allergen-specific immunotherapy
- Authors
- 강성윤; 정주현; 이상민; 이상표
- Issue Date
- Apr-2020
- Publisher
- 대한 소아알레르기 호흡기학회
- Keywords
- .; Allergen; Immunotherapy; Injections; Intralymphatic
- Citation
- Allergy Asthma & Respiratory Diseases, v.8, no.2, pp.53 - 65
- Journal Title
- Allergy Asthma & Respiratory Diseases
- Volume
- 8
- Number
- 2
- Start Page
- 53
- End Page
- 65
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/41904
- DOI
- 10.4168/aard.2020.8.2.53
- ISSN
- 2288-0402
- Abstract
- Although allergen-specific immunotherapy (AIT) is a standard treatment for allergic diseases, only 5% or less of patients in whom AIT is indicated have been receiving immunotherapy because AIT needs a long-term therapeutic duration of up to 5 years. To overcome this limitation of conventional AIT, Kündig and his colleagues first introduced intralymphatic immunotherapy (ILIT) in patients with allergic rhinitis, publishing their results in 2008. Since then, 10 clinical trials that evaluated therapeutic efficacies and adverse effects of ILIT have been conducted. This article reviews the clinical trials of ILIT and suggests unmet needs in research fields of ILIT.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/41904)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.